Pharmx Technologies Ltd (PHX) — Long-term Investment Intensity
Pharmx Technologies Ltd (PHX) has a Long-term Investment Intensity of 0.5% as of June 2022. Long-term investments of AU$148.00K represent 0.5% of total assets of AU$30.77 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See PHX total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pharmx Technologies Ltd Long-term Investment Intensity (2014–2022)
This chart shows how Pharmx Technologies Ltd's Long-term Investment Intensity has evolved across 9 annual periods from 2014 to 2022. As of June 2022, the intensity stands at 0.5%, reflecting long-term investments of AU$148.00K against total assets of AU$30.77 Million AUD. Also explore balance sheet size of Pharmx Technologies Ltd for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Pharmx Technologies Ltd (2014–2022)
The table below presents the year-by-year Long-term Investment Intensity for Pharmx Technologies Ltd from 2014 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PHX company net worth.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.5% | AU$148.00K | AU$30.77 Million | ▲ +0.3 pp |
| 2021 | 0.2% | AU$51.00K | AU$31.35 Million | ▼ -14.9 pp |
| 2020 | 15.0% | AU$2.88 Million | AU$19.18 Million | ▲ +13.9 pp |
| 2019 | 1.2% | AU$178.00K | AU$15.04 Million | ▲ +1.0 pp |
| 2018 | 0.2% | AU$30.00K | AU$19.73 Million | ▲ +0.0 pp |
| 2017 | 0.2% | AU$30.00K | AU$19.76 Million | ▲ +0.0 pp |
| 2016 | 0.1% | AU$30.00K | AU$26.03 Million | ▲ +0.0 pp |
| 2015 | 0.1% | AU$30.00K | AU$27.25 Million | ▼ 0.0 pp |
| 2014 | 0.1% | AU$30.00K | AU$27.24 Million | — |